Patients with JIA suffer poorer HRQOL than RA, general populations
Health-related quality of life (HRQOL) is lower in patients with juvenile idiopathic arthritis (JIA) than those with rheumatoid arthritis (RA) and the general population 6 months following the initiation of disease-modifying antirheumatic drug (DMARD) treatment, reveals a study. Both patient groups, however, enjoy similar improvement levels with treatment.